Mucormycosis following COVID19: clinical case and literature review

Autor:	Sofya N. Khostelidi, V.A. Zaytsev, E.V. Pelikh, E.V. Yashina, O.N. Rodionova, T.S. Bogomolova, Yu.L. Avdeenko, Nikolay N. Klimko
Rok vydání:	2021
Předmět:	Microbiology (medical) Epidemiology zygomycosis Infectious and parasitic diseases RC109-216 invasive fungal infection mucormycosis Microbiology QR1-502 rhino-orbital mucormycosis sars-cov-2 Infectious Diseases covid-19 rhizopus spp Pharmacology (medical)
Zdroj:	Клиническая микробиология и антимикробная химиотерапия, Vol 23, Iss 3, Pp 255-262 (2021)
ISSN:	2686-9586 1684-4386
DOI:	10.36488/cmac.2021.3.255-262
Popis:	Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%. This article provides the first description of mucormycosis in Russia after infection caused by SARS-CoV-2, as well as a review of literature reports on mucormycosis in patients with COVID-19 (as of September 2021).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff11e0516ca15dcd60398f7951a9a048 https://doi.org/10.36488/cmac.2021.3.255-262 Zobrazit plný text záznamu